Clozapine and Neutropenia in Patients with Schizophrenia and SARS-CoV-2 Infection

BACKGROUND: Clozapine (CLZ) is used for treatment-resistant schizophrenia (TRS). Adverse reactions to clozapine include neutropenia. In March 2020, WHO declared the COVID-19 pandemic and after, psychiatrists raised concerns regarding continuation of clozapine, due to multiple restrictions. We aimed...

Descripción completa

Detalles Bibliográficos
Autores principales: Moga, Silvia, Teodorescu, Andreea, Ifteni, Petru, Petric, Paula-Simina, Miron, Ana-Aliana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9081886/
https://www.ncbi.nlm.nih.gov/pubmed/35547265
http://dx.doi.org/10.2147/NDT.S361405

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9081886/
https://www.ncbi.nlm.nih.gov/pubmed/35547265
http://dx.doi.org/10.2147/NDT.S361405

Ejemplares similares